Linear IgA disease: Clinical presentation, diagnosis, and pathogenesis

Dermatologic Clinics

Volumn 29, Issue 3, 2011, Pages 453-458

  Venning, Vanessa A ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

CBDC; Chronic bullous dermatosis of childhood; LAD; Linear IgA disease

Indexed keywords

BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN A;

ADULT; AUTOIMMUNE SKIN DISEASE; BLISTER; BULLOUS SKIN DISEASE; CHILD; CHRONIC DISEASE; CLINICAL FEATURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; IGA PEMPHIGUS; IMMUNOFLUORESCENCE; IMMUNOGENETICS; IMMUNOGLOBULIN DEPOSITION; IMMUNOPATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

AGE OF ONSET; BASEMENT MEMBRANE; HUMANS; IMMUNOGLOBULIN A; SKIN; SKIN DISEASES, VESICULOBULLOUS;

EID: 79956268633     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.03.013     Document Type: Review

References (43)

1. Wojnarowska F., Marsden R.A., Bhogal B., et al. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol 1988, 19:792-805.
2. Adam B.A. Bullous diseases in Malaysia: epidemiology and natural history. Int J Dermatol 1992, 31:42-45.
3. Aboobaker J., Wojnarowska F.T., Bhogal B., et al. Chronic bullous dermatosis of childhood-clinical and immunological features seen in African patients. Clin Exp Dermatol 1991, 16:160-164.
4. Jin P., Shao C., Ye G. Chronic bullous dermatoses in China. Int J Dermatol 1993, 32:89-92.
5. Kishida Y., Kameyama J., Nei M., et al. Linear IgA bullous dermatosis of neonatal onset: case report and review of the literature. Acta Paediatr 2004, 93:850-852.
6. Collier P.M., Wojnarowska F., Welsh K., et al. Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression. Br J Dermatol 1999, 141:867-875.
7. Dellavalle R.P., Burch J.M., Tayal S., et al. Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. J Am Acad Dermatol 2003, 48:S56-S57.
8. Billet S.E., Kortuem K.R., Gibson L.E., et al. A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis. Arch Dermatol 2008, 144:774-778.
9. Collier P.M., Wojnarowska F. Drug-induced linear immunoglobulin A disease. Clin Dermatol 1993, 11:529-533.
10. Palmer R.A., Ogg G., Allen J., et al. Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285. Br J Dermatol 2001, 145:816-820.
11. Camilleri M., Pace J.L. Linear IgA bullous dermatosis induced by piroxicam. J Eur Acad Dermatol Venereol 1998, 10:70-72.
12. Bouldin M.B., Clowers-Webb H.E., Davis J.L., et al. Naproxen-associated linear IgA bullous dermatosis: case report and review. Mayo Clin Proc 2000, 75:967-970.
13. Girao L., Fiadeiro T., Rodrigues J.C. Burn-induced linear IgA dermatosis. J Eur Acad Dermatol Venereol 2000, 14:507-510.
14. Godfrey K., Wojnarowska F., Leonard J. Linear IgA disease of adults: association with lymphoproliferative malignancy and possible role of other triggering factors. Br J Dermatol 1990, 123:447-452.
15. Jacyk W.K., Nagel G.J., van der Hoven A.E. Linear IgA dermatosis and Hodgkin's lymphoma-report of a case in an African and review of the literature. J Dermatol 1990, 17:633-637.
16. Usmani N., Baxter K.F., Child J.A., et al. Linear IgA disease in association with chronic lymphocytic leukaemia. Br J Dermatol 2004, 151:710-711.
17. McEvoy M.T., Connolly S.M. Linear IgA dermatosis: association with malignancy. J Am Acad Dermatol 1990, 22:59-63.
18. van der Waal R.I., van de Scheur M.R., Pas H.H., et al. Linear IgA bullous dermatosis in a patient with renal cell carcinoma. Br J Dermatol 2001, 144:870-873.
19. Rodenas J.M., Herranz M.T., Tercedor J., et al. Linear IgA disease in a patient with bladder carcinoma. Br J Dermatol 1997, 136:257-259.
20. Paige D.G., Leonard J.N., Wojnarowska F., et al. Linear IgA disease and ulcerative colitis. Br J Dermatol 1997, 136:779-782.
21. Birnie A.J., Perkins W. A case of linear IgA disease occurring in a patient with colonic Crohn's disease. Br J Dermatol 2005, 153:1050-1052.
22. Sachs J.A., Leonard J., Awad J., et al. A comparative serological and molecular study of linear IgA disease and dermatitis herpetiformis. Br J Dermatol 1988, 118:759-764.
23. Leonard J.N., Griffiths C.E., Powles A.V., et al. Experience with a gluten free diet in the treatment of linear IgA disease. Acta Derm Venereol 1987, 67:145-148.
24. Leonard J.N., Haffenden G.P., Unsworth D.J., et al. Evidence that the IgA in patients with linear IgA disease is qualitatively different from that of patients with dermatitis herpetiformis. Br J Dermatol 1984, 110:315-321.
25. Marsden R.A., McKee P.H., Bhogal B., et al. A study of benign chronic bullous dermatosis of childhood and comparison with dermatitis herpetiformis and bullous pemphigoid occurring in childhood. Clin Exp Dermatol 1980, 5:159-176.
26. Burge S., Wojnarowska F., Marsden A. Chronic bullous dermatosis of childhood persisting into adulthood. Pediatr Dermatol 1988, 5:246-249.
27. Chan L.S., Ahmed A.R., Anhalt G.J., et al. The First International Consensus on Mucous Membrane Pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002, 138:370-379.
28. Collier P.M., Wojnarowska F., Millard P.R. Variation in the deposition of the antibodies at different anatomical sites in linear IgA disease of adults and chronic bullous disease of childhood. Br J Dermatol 1992, 127:482-484.
29. Leonard J.N., Haffenden G.P., Ring N.P., et al. Linear IgA disease in adults. Br J Dermatol 1982, 107:301-316.
30. Zhou S., Wakelin S.H., Allen J., et al. Blister fluid for the diagnosis of subepidermal immunobullous diseases: a comparative study of basement membrane zone autoantibodies detected in blister fluid and serum. Br J Dermatol 1998, 139:27-32.
31. Powell J., Kirtschig G., Allen J., et al. Mixed immunobullous disease of childhood: a good response to antimicrobials. Br J Dermatol 2001, 144:769-774.
32. Sheridan A.T., Kirtschig G., Wojnarowska F. Mixed immunobullous disease: is this linear IgA disease?. Australas J Dermatol 2000, 41:219-221.
33. Viglizzo G., Cozzani E., Nozza P., et al. A case of linear IgA disease in a child with IgA and IgG circulating antibodies directed to BPAg2. Int J Dermatol 2007, 46:1302-1304.
34. Allen J., Wojnarowska F. Linear IgA disease: the IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies, and is more common in adults. Br J Dermatol 2003, 149:977-985.
35. Hendrix J.D., Mangum K.L., Zone J.J., et al. Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils. J Invest Dermatol 1990, 94:667-672.
36. Zone J.J., Egan C.A., Taylor T.B., et al. IgA autoimmune disorders: development of a passive transfer mouse model. J Investig Dermatol Symp Proc 2004, 9:47-51.
37. Bhogal B., Wojnarowska F., Marsden R.A., et al. Linear IgA bullous dermatosis of adults and children: an immunoelectron microscopic study. Br J Dermatol 1987, 117:289-296.
38. Prost C., De Leca A.C., Combemale P., et al. Diagnosis of adult linear IgA dermatosis by immunoelectronmicroscopy in 16 patients with linear IgA deposits. J Invest Dermatol 1989, 92:39-45.
39. Hopkinson S.B., Baker S.E., Jones J.C. Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and alpha 6 integrin. J Cell Biol 1995, 130:117-125.
40. Lin M.S., Fu C.L., Olague-Marchan M., et al. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule. Clin Immunol 2002, 102:310-319.
41. Allen J., Wojnarowska F. Linear IgA disease: the IgA and IgG response to dermal antigens demonstrates a chiefly IgA response to LAD285 and a dermal 180-kDa protein. Br J Dermatol 2003, 149:1055-1058.
42. Nishie W., Lamer S., Schlosser A., et al. Ectodomain shedding generates neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid. J Immunol 2010, 185:4938-4947.
43. Zillikens D., Herzele K., Georgi M., et al. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801. J Invest Dermatol 1999, 113:947-953.